Cargando…

Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension

BACKGROUND/OBJECTIVE: Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary arterial pressure and pulmonary vascular resistance that can lead to right-sided heart failure. Connective tissue disease–associated PAH (CTD-PAH) often has poorer outcomes than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakayama, Kazuhiko, Nakajima, Yasuo, Tanaka, Rika, Hirata, Ken-ichi, Emoto, Noriaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612911/ https://www.ncbi.nlm.nih.gov/pubmed/32511146 http://dx.doi.org/10.1097/RHU.0000000000001447

Ejemplares similares

High perfusion pressure as a predictor of reperfusion pulmonary injury after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Kinutani, Hiroto, et al.
Publicado: (2015)

Combination therapy with pulmonary arterial hypertension targeted drugs and immunosuppression can be a useful strategy for sarcoidosis-associated pulmonary hypertension: a case report
por: Sumimoto, Keiko, et al.
Publicado: (2020)

Upfront triple combination therapy-induced pulmonary edema in a case of pulmonary arterial hypertension associated with Sjogren's syndrome
por: Takeuchi, Kimikazu, et al.
Publicado: (2017)

The optimization of iloprost inhalation under moderate flow of oxygen therapy in severe pulmonary arterial hypertension
por: Nakayama, Kazuhiko, et al.
Publicado: (2018)

Advanced Pulmonary Hypertension Due to Congenital Double-shunt Successfully Treated with Surgical Repair and Up-front Combination Therapy
por: Suto, Makiko, et al.
Publicado: (2019)

RC time (resistance × compliance) is related to residual symptom after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
por: Yanaka, Kenichi, et al.
Publicado: (2022)

Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reports: Strategy for ASD with Severe PAH
por: Taniguchi, Yu, et al.
Publicado: (2013)

Sequential Hybrid Therapy With Pulmonary Endarterectomy and Additional Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
por: Yanaka, Kenichi, et al.
Publicado: (2018)

Evaluation of microvasculopathy using dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension
por: Onishi, Hiroyuki, et al.
Publicado: (2021)

Successful Pulmonary Artery Embolization for the Management of Hemoptysis in a Patient with Eisenmenger Syndrome Caused by Patent Ductus Arteriosus
por: Tamada, Naoki, et al.
Publicado: (2017)

Acute Pulmonary Hypertension Crisis after Adalimumab Reduction in Rheumatoid Vasculitis
por: Yamasaki, Gentaro, et al.
Publicado: (2019)

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
por: Nishimori, Makoto, et al.
Publicado: (2018)

Reversible Parkinsonism and Multiple Cerebral Infarctions after Pulmonary Endarterectomy in a Patient with Antiphospholipid Syndrome
por: Okano, Mitsumasa, et al.
Publicado: (2018)

Pulmonary Endarterectomy and Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension　― Similar Effects on Health-Related Quality of Life ―
por: Tamada, Naoki, et al.
Publicado: (2019)

Optimal Cut-Off of Tricuspid Regurgitation Velocity According to the New Definition of Pulmonary Hypertension　― Its Use in Predicting Pulmonary Hypertension ―
por: Sumimoto, Keiko, et al.
Publicado: (2020)

Rescue balloon pulmonary angioplasty for life-threatening acute pulmonary embolism on chronic thromboembolic pulmonary hypertension patients
por: Sumimoto, Keiko, et al.
Publicado: (2021)

A rare case of intimal sarcoma mimicking pulmonary stenosis
por: Sumimoto, Keiko, et al.
Publicado: (2021)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
por: Miwa, Keisuke, et al.
Publicado: (2022)

Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension
por: Ryanto, Gusty Rizky Teguh, et al.
Publicado: (2023)

Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition
por: Rinastiti, Pranindya, et al.
Publicado: (2020)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension
por: Ryanto, Gusty R. T., et al.
Publicado: (2021)

Endothelial cell senescence exacerbates pulmonary hypertension by inducing juxtacrine Notch signaling in smooth muscle cells
por: Ramadhiani, Risa, et al.
Publicado: (2023)

Glycosaminoglycan Overproduction in the Aorta Increases Aortic Calcification in Murine Chronic Kidney Disease
por: Purnomo, Eko, et al.
Publicado: (2013)

Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease
por: Fujii, Hiroyuki, et al.
Publicado: (2023)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
por: Grünig, Ekkehard, et al.
Publicado: (2012)

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
por: Gaine, Sean, et al.
Publicado: (2017)

Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Moccaldi, Beatrice, et al.
Publicado: (2023)

The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease
por: Xiong, Jiangbiao, et al.
Publicado: (2022)

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients
por: Cavagna, Lorenzo, et al.
Publicado: (2016)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
por: Smukowska-Gorynia, Anna, et al.
Publicado: (2023)

Evaluation of pulmonary arterial pressure in patients with connective tissue disease‐associated pulmonary arterial hypertension by myocardial perfusion imaging
por: Wang, Zengyan, et al.
Publicado: (2021)

GPNMB plays a protective role against obesity-related metabolic disorders by reducing macrophage inflammatory capacity
por: Prabata, Adam, et al.
Publicado: (2021)

Pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials
por: Kuwana, Masataka, et al.
Publicado: (2013)

Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
por: Hernandez-Gonzalez, Ignacio, et al.
Publicado: (2021)

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension
por: Dong, Xingbei, et al.
Publicado: (2022)

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases
por: Denton, C P, et al.
Publicado: (2008)

Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension
por: Tam, Angela Y.Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dktokbrs19jhfe487348mlji9q